Swiss Re Insurance-Linked Fund Management

Xactanalysis Insights and PCS

vita capital iv


Swiss Re preparing Vita Capital IV mortality bond

18th November 2009

Various sources are reporting that Swiss Re is preparing to launch a fourth excess mortality transaction under its Vita series. Vita Capital IV is said to be a $75m mortality bond, it started as $50m but demand has been high and the deal has upsized significantly. It’s assumed that Vita Capital IV will replace a […]

Read the full article